Practice-changing abstracts in indolent lymphoma at EHA 2020
Автор: Lymphoma Hub
Загружено: 2020-07-21
Просмотров: 301
Описание:
During the 25th European Hematology Association (EHA) Annual Congress, the Lymphoma Hub was happy to speak to Martin Dreyling, University of Munich, Munich, DE, who outlined the practice-changing abstracts in indolent lymphoma.
Martin Dreyling highlights three particular areas that he believes will shape the treatment of indolent lymphomas in the near future:
1. Ibrutinib versus a second generation BTKi for the treatment of Waldenström macroglobulinemia
2. Triplet regimen (ibrutinib + venetoclax + obinutuzumab) for the treatment of mantle cell lymphoma
3. CAR T-cell therapy for the treatment of follicular lymphoma
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
